Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning vs. Evening Vaccination in Preterm Infants
NCT02640703Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of acellular pertussis vaccine, pneumococcal 13-valent conjugate vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by University Hospital Tübingen. Started Mar 2015; status: completed.
02
Drugs
acellular pertussis vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT02640703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640703.